Open access
Sep 2026
A luciferase-based high-throughput three-dimensional tumor spheroid model identifies a renieramycin T derivative with anti-cancer stem cell activity in non-small cell lung cancer.
A quantitative and scalable 3D NSCLC spheroid platform suitable for CSC-targeted drug screening and nominate DH_18 as a candidate compound with potential activity against stemness-linked molecular networks is reported.
P. Samart, Supasorn Chanthateyanonth, Napachai Rodboon et al.
· Biomedicine & pharmacotherap... · 0 citations